Inspire Medical Systems has appointed Matt Osberg as Executive Vice President and Chief Financial Officer, effective January ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Inspire Medical Systems’ growth strategy is focused on ensuring strong clinical outcomes, driving manufacturing capabilities, ...

Medicare Part B covers the cost of Inspire for sleep apnea and other FDA-approved medical devices as long as a doctor determines them to be medically essential for your care. For Original Medicare to ...

Waking up from a good night’s sleep, ready to take on the day, is a feeling we all strive for. Dr. Roland Gerencer is an Ear, Nose, and Throat physician for Health Specialists of New Mexico ...

WORCESTER — Do you have problems sleeping? If the answer is yes, you’re not alone. Roughly 14% of adults in the U.S. — more than one of every 10 grownups — had trouble falling sleep most days or every ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of two ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

Inspire Medical Systems is a rapidly growing medical technology company specializing in a device that treats Obstructive Sleep Apnea. The company is still in the early stages of developing their ...

Medicare may cover Inspire, a device to treat sleep apnea, if it is medically necessary. A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective. Inspire ...